Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Achenbach

Showing results (41-50 of 108) with videos related to

Pageof 11
Sort By:
Diabetologia|July 4, 2015
Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetesEleni Z Giannopoulou, Christiane Winkler, Ruth Chmiel, et al.
Clinical Immunology (Orlando, Fla.)|November 1, 2012
IA-2 autoantibody affinity in children at risk for type 1 diabetesStephanie Krause, Ruth Chmiel, Ezio Bonifacio, et al.
Diabetes|January 30, 2004
Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristicsPeter Achenbach, Katharina Warncke, Jürgen Reiter, et al.
Frontiers in Endocrinology|February 6, 2023
Methylglyoxal products in pre-symptomatic type 1 diabetesSarah C Shuck, Peter Achenbach, Bart O Roep, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|May 3, 2021
Modeling Disease Progression Trajectories from Longitudinal Observational DataBum Chul Kwon, Peter Achenbach, Jessica L Dunne, et al.
Diabetes Care|December 16, 2025
Stratifying the Rate of Disease Progression by Progression Likelihood Scores in Children and Adolescents With Stage 1 and Stage 2 Type 1 Diabetes in GermanyAndreas Weiss, Lenche Chakievska, Peter Achenbach, et al.
Diabetologia|July 13, 2016
A novel approach for the analysis of longitudinal profiles reveals delayed progression to type 1 diabetes in a subgroup of multiple-islet-autoantibody-positive childrenDavid Endesfelder, Michael Hagen, Christiane Winkler, et al.
Eclinicalmedicine|September 21, 2023
Characterisation and clinical outcomes in children and adolescents with diabetes according to newly defined subgroups: a cohort study from the DPV registryKatharina Warncke, Alexander Eckert, Ezio Bonifacio, et al.
Diabetologia|February 9, 2023
Islet Autoantibody Standardization Program: interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshopsIlaria Marzinotto, David L Pittman, Alistair J K Williams, et al.
Diabetologia|April 6, 2018
Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12Peter Achenbach, Mohammed I Hawa, Stephanie Krause, et al.
Pageof 11

Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
Diabetologia|July 4, 2015
Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetesEleni Z Giannopoulou, Christiane Winkler, Ruth Chmiel, et al.
Clinical Immunology (Orlando, Fla.)|November 1, 2012
IA-2 autoantibody affinity in children at risk for type 1 diabetesStephanie Krause, Ruth Chmiel, Ezio Bonifacio, et al.
Diabetes|January 30, 2004
Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristicsPeter Achenbach, Katharina Warncke, Jürgen Reiter, et al.
Frontiers in Endocrinology|February 6, 2023
Methylglyoxal products in pre-symptomatic type 1 diabetesSarah C Shuck, Peter Achenbach, Bart O Roep, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|May 3, 2021
Modeling Disease Progression Trajectories from Longitudinal Observational DataBum Chul Kwon, Peter Achenbach, Jessica L Dunne, et al.
Diabetes Care|December 16, 2025
Stratifying the Rate of Disease Progression by Progression Likelihood Scores in Children and Adolescents With Stage 1 and Stage 2 Type 1 Diabetes in GermanyAndreas Weiss, Lenche Chakievska, Peter Achenbach, et al.
Diabetologia|July 13, 2016
A novel approach for the analysis of longitudinal profiles reveals delayed progression to type 1 diabetes in a subgroup of multiple-islet-autoantibody-positive childrenDavid Endesfelder, Michael Hagen, Christiane Winkler, et al.
Eclinicalmedicine|September 21, 2023
Characterisation and clinical outcomes in children and adolescents with diabetes according to newly defined subgroups: a cohort study from the DPV registryKatharina Warncke, Alexander Eckert, Ezio Bonifacio, et al.
Diabetologia|February 9, 2023
Islet Autoantibody Standardization Program: interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshopsIlaria Marzinotto, David L Pittman, Alistair J K Williams, et al.
Diabetologia|April 6, 2018
Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12Peter Achenbach, Mohammed I Hawa, Stephanie Krause, et al.
Pageof 11